Market revenue in 2024 | USD 5,078.7 million |
Market revenue in 2030 | USD 7,519.8 million |
Growth rate | 6.8% (CAGR from 2025 to 2030) |
Largest segment | Arthritis |
Fastest growing segment | Migraine |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Arthritis, Migraine, Ophthalmic Diseases |
Key market players worldwide | Pfizer Inc, Bayer AG, GSK PLC ADR, Dr Reddy's Laboratories Ltd ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd ADR, Johnson & Johnson, Merck & Co Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account